Live · updated just now

One dose of psilocybin eased depression and improved self-image in small trial

Monday, 16 November 2026 · Mental health & wellbeing · Full report · Evidence: Moderate

What was found

In this trial, people with depression who received one moderate dose of psilocybin (0.215 mg per kg of body weight) had a larger drop in depressive symptoms two weeks later than those given a placebo 1. They also showed a bigger improvement in how positively they viewed themselves. The more a person's self-view improved, the more their symptoms tended to ease 12. Brain scans (fMRI) showed another difference involving the caudate, a region deep in the brain. After psilocybin, caudate activity changed during tasks that focused attention outward. After placebo, it changed during tasks where people reflected on themselves 2.

Who it applies to

Participants were right-handed adults aged 20 to 60 with a diagnosis of major depressive disorder. Their symptoms scored between 10 and 40 on the MADRS, a standard depression rating scale 2. They had no other diagnosed conditions, spoke German at a very high level, and had gradually stopped their psychiatric medications before the study 2. The results may not apply to people outside this group.

How strong the evidence is

Moderate. This was a randomized, double-blind, placebo-controlled trial that also used brain imaging, and the full text was read 12. However, only 37 people took part, and they were a smaller group drawn from a larger study 2. The link between a better self-view and fewer symptoms is an association, so it cannot show that one caused the other 2. The researchers also did not formally measure what participants expected from treatment. They did not check whether participants could tell which treatment they had received, either.